Prognostic Role of PGE2 Receptor EP2 in Esophageal Squamous Cell Carcinoma

Annals of Surgical Oncology

Volumn 16, Issue 2, 2009, Pages 352-360

  Kuo, Kuang Tai ^a,b   Wang, Hao Wei ^b   Chou, Teh Ying ^b,c   Hsu, Wen Hu ^c   Hsu, Han Shui ^c   Lin, Chi Hung ^b   Wang, Liang Shun ^d,e  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e EN CHU KONG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DINOPROSTONE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, PROSTAGLANDIN E; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 59449084521     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0242-2     Document Type: Article

References (35)

1. A Jemal R Siegel E Ward T Murray J Xu C Smigal 2006 Cancer statistics, 2006 CA Cancer J Clin 56 106 30
2. Department of Health, the Executive Yuan, Republic of China. Statistics of Causes of Death and Cancer Registry Annual Report in Taiwan area, 2005.
3. S Law DL Kwong KF Kwok KH Wong KM Chu JS Sham 2003 Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy Ann Surg 238 339 47
4. AC Berger J Farma WJ Scott 2005 Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival J Clin Oncol 23 4330 7
5. E Le Prise PL Etienne B Meunier 1994 A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer 73 1779 84
6. JF Bosset M Gignoux JP Triboulet 1997 Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 161 7
7. SG Urba MB Orringer A Turrisi M Iannettoni A Forastiere M Strawderman 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 305 13
8. MJ Thun MM Namboodiri EE Calle WD Flanders CW Heath Jr 1993 Aspirin use and risk of fatal cancer Cancer Res 53 1322 7
9. T Nozoe T Ezaki A Kabashima H Baba Y Maehara 2005 Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus Am J Surg 189 110 5
10. KT Kuo KC Chow YC Wu CS Lin HW Wang WY Li 2003 Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma Ann Thorac Surg 76 909 14
11. P Heeren J Plukker H van Dullemen R Nap H Hollema 2005 Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma Cancer Lett 225 283 9
12. A Sivula CJ Buskens BP van Rees C Haglund GJ Offerhaus JJ van Lanschot 2005 Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous carcinoma of the esophagus Int J Cancer 116 903 8
13. CJ Buskens BP van Rees A Sivula 2002 Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus Gastroenterology 122 1800 7
14. R Pai IL Szabo BA Soreghan S Atay H Kawanaka AS Tarnawski 2001 PGE(2) stimulates VEGF expression inendothelial cells via ERK2/JNK1 signaling pathways Biochem Biophys Res Commun 286 923 8
15. H Sheng J Shao MK Washington RN DuBois 2001 Prostaglandin E2 increases growth and motility of colorectal carcinoma cells J Biol Chem 276 18075 81
16. FG Buchanan D Wang F Bargiacchi RN DuBois 2003 Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor J Biol Chem 278 35451 7
17. RA Coleman WL Smith S Narumiya 1994 International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol Rev 46 205 29
18. I Dey M Lejeune K Chadee 2006 Prostaglandin E2 receptor distribution and unction in the gastrointestinal tract Br J Pharmacol 149 611 23
19. MD Castellone H Teramoto BO Williams KM Druey JS Gutkind 2005 Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 1504 10
20. M Sonoshita K Takaku N Sasaki 2001 Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc (Delta 716) knockout mice Nat Med 7 1048 51
21. SW Han J Roman 2004 Suppression of prostaglandin E2 receptor subtype EP2 by PPAR gamma ligands inhibits human lung carcinoma cell growth Biochem Biophys Res Commun 314 1093 9
22. M Kamiyama A Pozzi L Yang LM DeBusk RM Breyer PC Lin 2006 EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival Oncogene 25 7019 28
23. YM Sung G He DH Hwang SM Fischer 2006 Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development Oncogene 25 5507 16
24. E Piazuelo P Jiménez M Strunk S Santander A García F Esteva 2006 Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus Prostaglandins Other Lipid Mediat 81 150 61
25. L Yu WK Wu ZJ Li 2008 E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma J Pharmacol Exp Ther 327 258 67
26. LS Wang KC Chow CW Wu 1999 Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate Br J Cancer 80 1617 22
27. YF Wang KC Chow SY Chang JH Chiu SK Tai WY Li 2004 Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma Br J Cancer 90 2186 93
28. A Watabe Y Sugimoto A Honda 1993 Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor J Biol Chem 268 20175 8
29. A Honda Y Sugimoto T Namba 1993 Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype J Biol Chem 268 7759 62
30. Y Sugimoto T Namba A Honda Y Hayashi M Negishi A Ichikawa 1992 Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype J Biol Chem 267 6463 6
31. Y Miyata S Kanda K Nomata J Eguchi H Kanetake 2005 Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract J Urol 173 56 60
32. R Pai T Nakamura WS Moon AS Tarnawski 2003 Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors FASEB J 17 1640 7
33. F Spinella L Rosano V DiCastro PG Natali A Bagnato 2004 Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion J Biol Chem 279 46700 5
34. C Han T Wu 2005 Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt J Biol Chem 280 24053 63
35. C Han GK Michalopoulos T Wu 2006 Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells J Cell Physiol 207 261 70